Bevacizumab: increased risk of venous thromboembolism

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1230, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab: increased risk of venous thromboembolism

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Increased risk of death and thromboembolism with ESAs

By  

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Oral HRT doubles venous thromboembolism risk

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Risk of venous thromboembolism due to antipsychotic drug therapy

By Hägg Staffan   Jönsson Anna K   Spigset Olav  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

By Wolozinsky Mia   Yavin Yshai Y.   Cohen Alexander T.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 409-415

Adis International

Access to resources Recommend Favorite